Enforced expression of RASAL1 suppresses cell proliferation and the transformation ability of gastric cancer cells.

RAS protein activator like 1 (RASAL1) is a member of the RAS GTPase-activating protein (GAP) family, and it is an important molecule in the regulation of RAS activation. In the present study, we investigated the role of RASAL1 in gastric carcinogenesis. Decreased expression pattern of RASAL1 in gastric cancer tissues and cell lines was found in protein and RNA levels, although there was no statistically significant relationship between RASAL1 and clinicopathological features. Restored expression of RASAL1 induced by DNA methylation inhibitor 5-aza-2'-deoxycytidine (5'-AZA) and HDAC inhibitor trichostatin A (TSA) implied that RASAL1 expression is regulated by epigenetic mechanisms. The biological role of RASAL1 in gastric carcinogenesis was determined by in vitro tumorigenicity assays. Overexpression of RASAL1 showed suppression of cell proliferation due to cell apoptosis. Subsequently, enforced expression of RASAL1 repressed significantly the gastric cancer cell transformation ability. These findings demonstrated that decreased RASAL1 expression is a characteristic of gastric cancer and regulated by epigenetic mechanisms. RASAL1 may be a functional tumor suppressor involved in gastric cancer. This study provides novel insights into the biological role of RASAL1 in gastric carcinogenesis.

[1]  A. Rustgi,et al.  Systemic activation of K-ras rapidly induces gastric hyperplasia and metaplasia in mice. , 2011, American journal of cancer research.

[2]  M. Otsuka,et al.  Reduced expression of RAS protein activator like‐1 in gastric cancer , 2011, International journal of cancer.

[3]  S. Thorgeirsson,et al.  Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. , 2011, Journal of hepatology.

[4]  Chengyu Lv,et al.  Expression pattern and clinical significance of DNA methyltransferase 3B variants in gastric carcinoma. , 2010, Oncology reports.

[5]  T. Sawada,et al.  Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells. , 2009, International journal of oncology.

[6]  Zhi-Min Liu,et al.  Mutation detection of KRAS by high-resolution melting analysis in Chinese with gastric cancer. , 2009, Oncology reports.

[7]  Christiane Garbay,et al.  p120-Ras GTPase activating protein (RasGAP): a multi-interacting protein in downstream signaling. , 2009, Biochimie.

[8]  Zhong-ying Shen,et al.  Epigenetic silencing of a Ca2+-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers , 2007, Proceedings of the National Academy of Sciences.

[9]  L. Parada,et al.  Tumor microenvironment and neurofibromatosis type I: connecting the GAPs , 2007, Oncogene.

[10]  C. Enrich,et al.  Molecular mechanisms involved in Ras inactivation: the annexin A6–p120GAP complex , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[11]  P. Cullen,et al.  The GAP1 family of GTPase-activating proteins: spatial and temporal regulators of small GTPase signalling. , 2006, Biochemical Society transactions.

[12]  C. Der,et al.  Signaling Interplay in Ras Superfamily Function , 2005, Current Biology.

[13]  R. Bernards,et al.  A Genetic Screen Identifies PITX1 as a Suppressor of RAS Activity and Tumorigenicity , 2005, Cell.

[14]  J. Settleman,et al.  GAPs in growth factor signalling , 2005, Growth factors.

[15]  J. Downward.  Role of receptor tyrosine kinases in G-protein-coupled receptor regulation of Ras: transactivation or parallel pathways? , 2003, The Biochemical journal.

[16]  J. Hancock,et al.  Ras proteins: different signals from different locations , 2003, Nature Reviews Molecular Cell Biology.

[17]  D. Gutmann,et al.  Neurofibromatosis 1: closing the GAP between mice and men. , 2003, Current opinion in genetics & development.

[18]  Peter J. Cullen,et al.  Integration of calcium and RAS signalling , 2002, Nature Reviews Molecular Cell Biology.

[19]  Gideon Bollag,et al.  GTPase activating proteins: critical regulators of intracellular signaling. , 2002, Biochimica et biophysica acta.

[20]  T. Kawabe,et al.  Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression. , 2009, Gastroenterology.